Cargando…

Effect of dexmedetomidine on lung ischemia-reperfusion injury

Dexmedetomidine, a specific selective α(2)-adrenergic agonist, does not only have the characteristics of being a sedative and analgesic, but also exhibits a protective role in brain ischemia-reperfusion injury and inhibits the inflammation in animals with sepsis. The objective of the present study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	JIANG, LILI, LI, LI, SHEN, JINMEI, QI, ZEYOU, GUO, LIANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896524/ https://www.ncbi.nlm.nih.gov/pubmed/24345905 http://dx.doi.org/10.3892/mmr.2013.1867

Ejemplares similares

Effect of dexmedetomidine pretreatment on lung injury following intestinal ischemia-reperfusion
por: SHEN, JINMEI, et al.
Publicado: (2013)

The activation of SIRT3 by dexmedetomidine mitigates limb ischemia-reperfusion–induced lung injury
por: Wang, Lei, et al.
Publicado: (2022)

Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014)

The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury
por: Tang, Ying, et al.
Publicado: (2019)

Pretreatment with dexmedetomidine alleviates lung injury in a rat model of intestinal ischemia reperfusion
por: Chen, Yaping, et al.
Publicado: (2020)

Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice
por: Gu, Jianteng, et al.
Publicado: (2011)

Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020)

The preventive effects of dexmedetomidine against intestinal ischemia-reperfusion injury in Wistar rats
por: Zhang, Xue-kang, et al.
Publicado: (2015)

The effect of dexmedetomidine on gastric ischemia reperfusion injury in rats. Biochemical and histopathological evaluation
por: Kuyrukluyildiz, Ufuk, et al.
Publicado: (2021)

Dexmedetomidine preconditioning protects against lung injury induced by ischemia-reperfusion through inhibition of autophagy
por: Zhang, Wei, et al.
Publicado: (2017)

Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats
por: Bao, Naren, et al.
Publicado: (2020)

Dexmedetomidine and Phosphocreatine Post-treatment Provides Protection against Focal Cerebral Ischemia-reperfusion Injury in Rats
por: Sun, Xiaofen, et al.
Publicado: (2021)

Effects of dexmedetomidine on renal microcirculation in ischemia/reperfusion-induced acute kidney injury in rats
por: Yang, Szu-Jen, et al.
Publicado: (2021)

Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress
por: Li, Jinjie, et al.
Publicado: (2019)

Dexmedetomidine Pretreatment Protects Against Myocardial Ischemia/Reperfusion Injury by Activating STAT3 Signaling
por: Chen, Zhao-Rong, et al.
Publicado: (2023)

Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion
por: Fan, Xin, et al.
Publicado: (2019)

Therapeutic effect of berberine on renal ischemia-reperfusion injury in rats and its effect on Bax and Bcl-2
por: Zheng, Haiya, et al.
Publicado: (2018)

Use of dexmedetomidine to alleviate intestinal ischemia-reperfusion injury via intestinal microbiota modulation in mice
por: Dong, Ye-Hong, et al.
Publicado: (2022)

Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021)

Dexmedetomidine attenuates cerebral ischemia/reperfusion injury in neonatal rats by inhibiting TLR4 signaling
por: Cheng, Jiangxia, et al.
Publicado: (2018)

Protective Effects of Dexmedetomidine and Oxycodone in Patients Undergoing Limb Ischemia-Reperfusion
por: Cheng, Wenjie, et al.
Publicado: (2019)

Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation
por: Si, Yanna, et al.
Publicado: (2013)

Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway
por: Liu, Huan, et al.
Publicado: (2022)

Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis
por: Chen, Siyu, et al.
Publicado: (2022)

Dexmedetomidine Protects Human Cardiomyocytes Against Ischemia-Reperfusion Injury Through α2-Adrenergic Receptor/AMPK-Dependent Autophagy
por: Xiao, Yingying, et al.
Publicado: (2021)

Ischemia–Reperfusion Injury in Lung Transplantation
por: Chen-Yoshikawa, Toyofumi Fengshi
Publicado: (2021)

Dexmedetomidine inhibits neuronal apoptosis by inducing Sigma-1 receptor signaling in cerebral ischemia-reperfusion injury
por: Zhai, Meili, et al.
Publicado: (2019)

Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury
por: CHENG, XIANG YANG, et al.
Publicado: (2016)

Dexmedetomidine Alleviates Lung Oxidative Stress Injury Induced by Ischemia-Reperfusion in Diabetic Rats via the Nrf2-Sulfiredoxin1 Pathway
por: Wang, Xuan, et al.
Publicado: (2022)

Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
por: Yang, Ke, et al.
Publicado: (2023)

Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
por: Zhang, Xiong, et al.
Publicado: (2020)

Correction to: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021)

Effects of dexmedetomidine on renal tissue after lower limb ischemia reperfusion injury in streptozotocin induced diabetic rats
por: Erbatur, Meral Erdal, et al.
Publicado: (2017)

Effect of intraoperative dexmedetomidine on hepatic ischemia-reperfusion injury in pediatric living-related liver transplantation: A propensity score matching analysis
por: Zhang, Liang, et al.
Publicado: (2022)

Effects of Lycopene Attenuating Injuries in Ischemia and Reperfusion
por: Wu, Sijia, et al.
Publicado: (2022)

The Protective Effect of Dexmedetomidine Against Ischemia-Reperfusion Injury after Hepatectomy: A Meta-Analysis of Randomized Controlled Trials
por: Huang, Ya-Qun, et al.
Publicado: (2021)

Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?
por: Erkılıç, E, et al.
Publicado: (2017)

Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1
por: Guo, Qingduo, et al.
Publicado: (2023)

Oxidative Stress and Lung Ischemia-Reperfusion Injury
por: Ferrari, Renata Salatti, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vsf4r65rmbui6fll3uq6df7r32